Seattle Genetics Inc. (SGEN)

Last Three Months

30-Aug-23 -- 29-Nov-23

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

45

0

0

+1

0

+2

0

+3

Two Year Chart

30-Nov-21 -- 29-Nov-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
22-Sep-23 7:45 PM View:	21-Sep-23 Private Sale (Planned) ($16.52K)	Simpson Todd E Chief Financial Officer		Seattle Genetics Inc. - SGEN	(2%) 130.93K to 128.72K	0	0	--	--	Show Txns Hide Txns

13-Nov-23 7:32 PM View:	09-Nov-23 Private Sale (Planned) ($1.87M)	Himes Vaughn B Chief Technical Officer		Seattle Genetics Inc. - SGEN	(6%) 172.71K to 162.04K	0	0	--	--	Show Txns Hide Txns

22-Sep-23 7:47 PM View:	21-Sep-23 Private Sale (Planned) ($13.22K)	Liu Jean I Chief Legal Officer		Seattle Genetics Inc. - SGEN	(2%) 86.36K to 84.4K	0	0	--	--	Show Txns Hide Txns

22-Sep-23 7:51 PM View:	21-Sep-23 Sale (Planned) ($14.66K)	Dansey Roger D President, R&D & CMO		Seattle Genetics Inc. - SGEN	1% 115.8K to 116.68K	0	0	--	--	Show Txns Hide Txns

22-Sep-23 7:46 PM View:	21-Sep-23 Private Sale (Planned) ($9.29K)	Romp Charles R EVP, Commercial U.S.		Seattle Genetics Inc. - SGEN	(1%) 69.71K to 69.11K	0	0	--	--	Show Txns Hide Txns

13-Nov-23 8:02 PM View:	10-Nov-23 Private Sale (Planned) ($2.26M)	Epstein David R CEO Director		Seattle Genetics Inc. - SGEN	(7%) 147.22K to 136.6K	0	0	--	--	Show Txns Hide Txns